Skip to main content
Clinical Trials/NCT01952405
NCT01952405CompletedNot Applicable

Efficacy of Dialectical Behavior Therapy in Patients With Borderline Personality Disorder: a Controlled Trial in Taiwan

Mackay Memorial Hospital1 site in 1 country60 target enrollmentStarted: May 18, 2013Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
60
Locations
1
Primary Endpoint
Suicide Attempt Self-Injury Interview (SASII)

Study Overview

Brief Summary

The purpose of this study is to test the hypothesis:

Primary hypothesis: Participants in the dialectical behavior therapy group have greater reductions in the frequency and severity of suicidal and non-suicidal self-injurious behaviors compared to participants in the alternative treatment group.

Secondary Hypotheses: Participants in dialectical behavior therapy group have improved treatment outcomes compared to participants in alternative treatment, including mental health service utilization, symptoms of borderline personality and depression symptoms, suicidal thought and hopelessness, disability, and quality of life.

Detailed Description

This study will be a 3-year randomized control trial. Patients will be referred from any mental health services in Taipei area who meet Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision criteria for Borderline Personality Disorder. Inclusion criteria include subjects who fulfill the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision criteria for Borderline Personality Disorder, 18-60 years of age, sign the informed consent, have had at least two episodes of suicidal or non-suicidal self-injurious episodes in the past 5 years, and at least one of which is in the 3 months preceding enrollment. The exclusion criteria include psychotic disorder, bipolar I disorder, severe physical illness, and mental retardation. Outcome measures will be obtained at pre-treatment, 4-month, 8-month and post-treatment (12-month) during 1-year protocol. Using semi-structured interview and a battery of self-report forms, a range of symptoms and behaviors associated with Borderline Personality Disorder will be assessed including suicidal thought, suicide attempt, depression, hopelessness, quality of life, disability, service utilization, and function. Measures are selected based on previous outcome studies of dialectical behavior therapy. Outcome variables will be evaluated by blinded assessors.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 60 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •meeting DSM-IV criteria for borderline personality disorder
  • •18-60 years of age
  • •have had at least two episodes of suicidal or non-suicidal self-injurious episodes in the past 5 years,
  • •at least one episode of suicidal is in the 3 months preceding enrollment
  • •agreement to participate in evaluation of the program.

Exclusion Criteria

  • •bipolar I disorder, delirium, dementia, mental retardation, or a diagnosis of substance dependence in the preceding 30 days
  • •living outside of Taipei area
  • •having any serious medical condition likely to require hospitalization within the next year (e.g. cancer)
  • •and having plans to leave the Taipei area in the next 1 year

Arms & Interventions

Dialectical behavior therapy

Experimental

Dialectical behavior therapy (DBT), developed by Marsha Linehan, has gained widespread popularity as a treatment for BPD, and its efficacy has been demonstrated in several trials.

Intervention: Dialectical behavior therapy (DBT) (Behavioral)

alternative psychotherapy

Placebo Comparator

The therapists of the alternative psychotherapy in the comparison group are asked to provide the type and dose of therapy that they believed is most suited to the patient, with a minimum of 1 scheduled individual session per week. Ancillary treatment could be prescribed as needed. Case management strategies are also available in the comparison group (alternative psychotherapy group). No restrictions are placed on ancillary pharmacotherapy in either condition.

Intervention: Dialectical behavior therapy (DBT) (Behavioral)

Outcomes

Primary Outcomes

Suicide Attempt Self-Injury Interview (SASII)

Time Frame: 4 months, 8 months and 12 months

change from baseline in Suicide Attempt Self-Injury Interview at 4 months, 8 months and 12 months

Secondary Outcomes

  • The Patient Health Questionnaire (PHQ-9)(4 months, 8 months and 12 months)
  • Symptom Checklist-90-Revised (SCL-90-R)(4 months , 8 months and 12 months)
  • Treatment History Interview (THI)(4 months, 8 months and 12 months)
  • Borderline Personality Disorder Subscale(4 months, 8 months and 12 months)
  • Brief Disability Questionnaire (BDQ)(4 months, 8 months and 12 months)
  • Borderline Symptom Checklist (BSL-23)(4 months, 8 months and 12 months)
  • Beck Scale for Suicide Ideation (BSSI)(4 months , 8months and 12 months)
  • Quality of Life Enjoyment and Satisfaction Questionnaire-Short Form (Q-LES-Q SF)(4 months, 8 months and 12 months)
  • Clinical Global Impressions-Severity (CGI-S) and Improvement (CGI-I)(4 months, 8 months and 12 months)
  • Beck Hopelessness Scale (BHS)(4 months, 8 months and 12months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Shen-Ing,Liu

Senior Visiting Staff

Mackay Memorial Hospital

Study Sites (1)

Loading locations...

Similar Trials